Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
PiNACLE pivotal clinical trial evaluating ronde-cel in patients with LBCL in third- or later-line setting on track to report additional data in second half of 2026, with pivotal data expected mid-2027...
-
California Resources Corporation Reports First Quarter 2026 Financial and Operating Results
-
Carbon TerraVault Provides First Quarter 2026 Update
-
California Resources Corporation Schedules First Quarter 2026 Earnings Conference Call
-
Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal...
-
California Resources Corporation Announces Pricing of Upsized Private Offering of $350 Million of Additional 7.000% Senior Unsecured Notes due 2034
-
California Resources Corporation Announces Private Offering of Additional 7.000% Senior Unsecured Notes due 2034
-
California Resources Corporation Reports Fourth Quarter and Full-Year 2025 Financial and Operating Results; Announces 2026 Guidance
-
Carbon TerraVault Provides 2025 Update
-
California Resources Corporation Achieves ‘Grade A’ Certification for its San Joaquin Valley Basin Assets